Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Digoxin

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT02624765Phase 3Completed

Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)

Showing all 1 trials

Research Network

Common Treatments

  • Digoxin1
  • Flecainide Dual Therapy1
  • Sotalol1
  • Flecainide1
  • Digoxin Dual Therapy1

Active Sponsors

  • Edgar Jaeggi1
  • Canadian Institutes of Health Research (CIHR)1

Top Investigators

Related Conditions

  • Fetal Atrial Flutter Without Hydrops1
  • Fetal Supraventricular Tachycardia Without Hydrops1

Activity Timeline